Question 1

Does Glenview Capital Management own TEVA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Glenview Capital Management holds 5,081,091 shares of TEVA (Teva Pharmaceutical Industries), worth $172.1M.

Question 2

How many shares of TEVA does Glenview Capital Management own?

Accepted Answer

As of its Q2 2026 13F, Glenview Capital Management holds 5,081,091 shares of TEVA (Teva Pharmaceutical Industries).

Question 3

What is Glenview Capital Management's TEVA position worth?

Accepted Answer

As of its Q2 2026 13F, Glenview Capital Management's TEVA position is worth $172.1M.

Question 4

Is Glenview Capital Management buying or selling TEVA?

Accepted Answer

In Q2 2026, Glenview Capital Management reduced its TEVA position by 1,579,129 shares (-23.7%).

Question 5

When did Glenview Capital Management first buy TEVA?

Accepted Answer

Glenview Capital Management first reported TEVA in its Q4 2023 13F and has listed it in 11 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	5.1M	-23.7%	$172.1M	3.1%	$33.88	0
2026-Q1	Decreased	6.7M	-60.2%	$200.6M	5.0%	$30.12	0
2025-Q4	Increased	16.7M	+0.2%	$521.8M	10.6%	$31.21	61
2025-Q3	Increased	16.7M	+5.5%	$337.2M	7.5%	$20.20	64
2025-Q2	Increased	15.8M	+7.1%	$265.2M	7.4%	$16.76	65
2025-Q1	Increased	14.8M	+74.8%	$227.1M	5.6%	$15.37	91
2024-Q4	Unchanged	8.5M	0.0%	$186.4M	4.7%	$22.04	0
2024-Q3	Decreased	8.5M	-7.7%	$152.4M	2.9%	$18.02	0